In addition, albumin-bilirubin (ALBI) score, which used to assess the severity of liver dysfunction in hepatocellular carcinoma (HCC) patients, was developed to evaluate the prognosis of ACLF patients lately [11–13]. The gene discussed is ALB; the disease is hepatocellular carcinoma.